The AUC of using the NIC in the VP to predict EGFR gene mutation in NSCLC was 0.772 with a sensitivity and specificity of 72.4% and 80.6%, respectively, and the diagnostic threshold was 0.41. This evidence concerns the gene EGFR and non-small cell lung carcinoma.